Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Pfizer
Company Monitoring Page for Pfizer
latest headlines for company on cafepharma
Pfizer, Astellas' Xtandi matches J&J's rival Erleada with new prostate cancer nod
Fierce Pharma
Mon, 12/16/19 - 10:37 pm
Tags:
Pfizer
,
Astellas
,
Xtandi
,
prostate cancer
,
JNJ
,
Erleada
,
FDA
FDA Approves Pfizer's Extended Release Xeljanz for Ulcerative Colitis
BioSpace
Fri, 12/13/19 - 12:21 pm
Tags:
Pfizer
,
Xeljanz XR
,
FDA
,
ulcerative colitis
Pfizer to debut podcast series around vaccines, probing scientific, cultural and political issues
Fierce Pharma
Wed, 12/11/19 - 10:30 am
Tags:
Pfizer
,
vaccines
,
podcasts
,
drug marketing
Sangamo keeps pressure on rivals with updated hemophilia data
Biopharma Dive
Sat, 12/7/19 - 11:48 pm
Tags:
ASH2019
,
Pfizer
,
Sangamo
,
hemophilia
,
SB-525
An old, controversial Pfizer drug shows mid-stage efficacy against narcolepsy
Endpoints
Wed, 12/4/19 - 10:37 am
Tags:
Pfizer
,
narcolepsy
,
reboxetine
Pfizer, Novartis lead $2 billion spending spree on gene therapy production
Reuters
Wed, 11/27/19 - 12:36 pm
Tags:
gene therapy
,
drug manufacturing
,
Pfizer
,
Novartis
,
Bluebird Bio
,
PTC Therapeutics
,
Krystal Biotech
Takeda sets sights on first-line lung cancer market with new Alunbrig data
Pharmaforum
Mon, 11/25/19 - 09:49 am
Tags:
Takeda
,
Alunbrig
,
clinical trials
,
Pfizer
,
Xalkori
,
ALK-positive non-small cell lung cancer
Takeda eyes Alunbrig earlier lung cancer use as 2-year data trounce Pfizer’s Xalkori
Fierce Pharma
Sat, 11/23/19 - 04:12 pm
Tags:
Pfizer
,
Xalkori
,
ALK-positive non-small cell lung cancer
,
Takeda
,
Alunbrig
Watch Out, Pfizer: This $2 Billion Biotech Is Coming for You
Motley Fool
Sat, 11/23/19 - 04:11 pm
Tags:
Pfizer
,
Vyndaqel
,
ATTR-CM
,
Eidos Therapeutics
,
AG10
Looking for a Biotech Stock That's an Ideal Buyout Candidate? This Is It.
Motley Fool
Wed, 11/20/19 - 10:02 am
Tags:
Amarin
,
Vascepa
,
M&A
,
Amgen
,
Novartis
,
Pfizer
AZ, Merck and Novartis top Big Pharma's Q3 growth charts. Teva and Pfizer? Not so much
Fierce Pharma
Tue, 11/19/19 - 11:38 pm
Tags:
earnings
,
Big Pharma
,
AstraZeneca
,
Merck
,
Celgene
,
Novartis
,
Novo Nordisk
,
Pfizer
Top 10 pharma settlements since 2018
Fierce Pharma
Tue, 11/19/19 - 10:27 am
Tags:
settlements
,
Reckitt Benckiser
,
JNJ
,
Bayer
,
Allergan
,
Actelion
,
Purdue Pharma
,
Teva Pharmaceutical
,
Endo
,
Teikoku
,
Insys
,
Pfizer
,
GSK
,
Astellas
,
Amgen
FDA approves latest Humira near-copy, as dozens of biosimilars head for market
Pharmaforum
Mon, 11/18/19 - 10:11 am
Tags:
FDA
,
Pfizer
,
biosimilars
,
Humira
,
AbbVie
,
Abrilada
Pfizer, BMS look to early atrial fibrillation screening for potential Eliquis boost
Fierce Pharma
Sun, 11/17/19 - 08:50 pm
Tags:
Pfizer
,
Eliquis
,
Bristol-Myers Squibb
,
atrial fibrillation
Pfizer's Xeljanz gets EMA blood clots warning following FDA's similar move
Fierce Pharma
Sat, 11/16/19 - 10:27 pm
Tags:
Europe
,
EMA
,
ulcerative colitis
,
Pfizer
,
Xeljanz
Pfizer's Upjohn and Mylan will become Viatris. Wait, haven't we heard that name before?
Fierce Pharma
Tue, 11/12/19 - 07:57 pm
Tags:
Mylan
,
Pfizer
,
Upjohn
,
M&A
,
generics
,
Viatris
Pfizer's 'brainstorming' payment deals as gene therapies advance
Fierce Pharma
Fri, 11/8/19 - 12:11 pm
Tags:
Pfizer
,
gene therapy
,
outcomes-based pricing
Merck KGaA, Pfizer drug fails to meet endpoints in gastric cancer trial
Marketwatch
Fri, 11/8/19 - 10:45 am
Tags:
Merck KGaA
,
Pfizer
,
Bavencio
,
clinical trials
,
gastric cancer
Think Mylan's done with M&A after its Pfizer deal? Think again
Fierce Pharma
Tue, 11/5/19 - 11:49 pm
Tags:
Mylan
,
Pfizer
,
M&A
,
Upjohn
,
generics
Biopharma Q3: Pfizer, Merck, Amgen, Incyte and J&J
BioSpace
Sat, 11/2/19 - 07:55 pm
Tags:
earnings
,
Pfizer
,
Merck
,
Amgen
,
Incyte
,
JNJ
Pages
« first
‹ previous
…
77
78
79
80
81
82
83
84
85
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.